78 related articles for article (PubMed ID: 6687999)
1. [Local administration of radiosensitizer misonidazole].
Otsuka S; Suda K; Yamashita J; Gi H; Oda Y; Takeuchi J; Handa H; Ono K
No To Shinkei; 1983 Mar; 35(3):249-55. PubMed ID: 6687999
[No Abstract] [Full Text] [Related]
2. [Radiosensitizing effect of misonidazole in radiotherapy for intracranial tumors].
Otsuka S
Nihon Geka Hokan; 1982 Nov; 51(6):892-906. PubMed ID: 7171270
[No Abstract] [Full Text] [Related]
3. [Clinical experiences with the radiosensitizer Misonidazol (author's transl)].
Bamberg M; Tamulevicius P; Streffer C; Scherer E
Strahlentherapie; 1981 Aug; 157(8):524-36. PubMed ID: 7268822
[No Abstract] [Full Text] [Related]
4. [Postoperative radiotherapy of astrocytomas grade 3 and 4 with the radiosensitizer misonidazole. -End results of a multicentric controlled German study].
Sack H; Calcanis A; Godehardt E; Weidtman V; Zülch KJ; Ammon J; Bamberg M; Herbst M; Keim H; Kleibel F; Makoski HB; Potthoff PC; Schlegel G; Schnepper E
Strahlentherapie; 1982 Aug; 158(8):466-9. PubMed ID: 6753245
[TBL] [Abstract][Full Text] [Related]
5. [Radiosensitizing effect of misonidazole on intracranially transplanted tumors in mice and its clinical application (author's transl)].
Otsuka S; Suda K; Yumitori K; Yamashita J; Oda Y; Takeuchi J; Handa H; Ono K
Neurol Med Chir (Tokyo); 1982 May; 22(5):337-43. PubMed ID: 6180334
[No Abstract] [Full Text] [Related]
6. I.V. misonidazole (NSC 261037). Report of initial clinical experience.
Schwade JG; Strong JM; Gangji D
Cancer Clin Trials; 1981; 4(1):33-9. PubMed ID: 7214660
[No Abstract] [Full Text] [Related]
7. [Clinical studies of combined therapy of radiation and local injection of misonidazole].
Hong SS; Abe Y; Isobe Y; Yamakawa M; Kaneta K; Kawaguchi T; Matsuzawa T; Umegaki Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1983 May; 43(5):675-84. PubMed ID: 6622246
[No Abstract] [Full Text] [Related]
8. Radiation Therapy Oncology Group clinical trials with misonidazole.
Wasserman TH; Stetz J; Phillips TL
Cancer; 1981 May; 47(10):2382-90. PubMed ID: 7023642
[TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetics and tumor and neural tissue penetrating properties of SR-2508 and SR-2555 in the dog--hydrophilic radiosensitizers potentially less toxic than misonidazole.
White RA; Workman P; Brown JM
Radiat Res; 1980 Dec; 84(3):542-61. PubMed ID: 6450431
[No Abstract] [Full Text] [Related]
10. Misonidazole cytotoxicity in vivo: a comparison of large single doses with smaller doses and extended contact of the drug with tumor cells.
Conroy PJ; Sutherland RM; Passalacqua W
Radiat Res; 1980 Jul; 83(1):169-89. PubMed ID: 7394163
[No Abstract] [Full Text] [Related]
11. Clinical studies with misonidazole.
Wiltshire CR; Workman P; Watson JV; Bleehen NM
Br J Cancer Suppl; 1978 Jun; 3():286-9. PubMed ID: 277246
[TBL] [Abstract][Full Text] [Related]
12. [Clinical experiences with the radiation-sensitizing agent misonidazole].
Kogelnik HD; Szepesi T; Kärcher KH; Seitz W
Strahlentherapie Sonderb; 1978; 75():115-9. PubMed ID: 162327
[No Abstract] [Full Text] [Related]
13. Fast neutrons and misonidazole for malignant astrocytomas.
Kurup PD; Pajak TF; Hendrickson FR; Nelson JS; Mansell J; Cohen L; Awschalom M; Rosenberg I; Ten Haken RK
Int J Radiat Oncol Biol Phys; 1985 Apr; 11(4):679-86. PubMed ID: 2984151
[TBL] [Abstract][Full Text] [Related]
14. A randomized study of misonidazole and radiotherapy for grade 3 and 4 cerebral astrocytoma.
Bleehen NM; Wiltshire CR; Plowman PN; Watson JV; Gleave JR; Holmes AE; Lewin WS; Treip CS; Hawkins TD
Br J Cancer; 1981 Apr; 43(4):436-42. PubMed ID: 7016157
[TBL] [Abstract][Full Text] [Related]
15. The metabolism and pharmacokinetics of the hypoxic cell radiosensitizer and cytotoxic agent, misonidazole, in C3H mice.
Chin JB; Rauth AM
Radiat Res; 1981 May; 86(2):341-57. PubMed ID: 7232696
[No Abstract] [Full Text] [Related]
16. Misonidazole dose and tumor level relationships. Effects of individual variation in rate of misonidazole metabolism and absorption from the gastrointestinal tract.
Strong JM; Schwade JG; Gangji D; Shoemaker DD; Upton DK
Cancer Clin Trials; 1981; 4(1):41-6. PubMed ID: 7214661
[No Abstract] [Full Text] [Related]
17. Misonidazole as a radiosensitizer in the radiotherapy of glioblastomas and oesophageal cancer. Pharmacokinetic and clinical studies.
Tamulevicius P; Bamberg M; Scherer E; Streffer C
Br J Radiol; 1981 Apr; 54(640):318-24. PubMed ID: 7013890
[TBL] [Abstract][Full Text] [Related]
18. [Combined use of amifostine and misonidazole in experimental radiotherapy].
Tsukiyama I
Nihon Igaku Hoshasen Gakkai Zasshi; 1983 Apr; 43(4):613-21. PubMed ID: 6310492
[No Abstract] [Full Text] [Related]
19. [Clinical experience with daily doses of misonidazole (author's transl)].
Kogelnik HD; Reinartz G; Szepesi T; Seitz W; Wurst F; Mamoli B; Wessely P; Stark H
Strahlentherapie; 1980 Nov; 156(11):758-64. PubMed ID: 7434385
[TBL] [Abstract][Full Text] [Related]
20. [Clinical testing of the radiosensitizer RO-07-0582 (misonidazole). Dose tolerance, toxicity and pharmacokinetic studies, preliminary report (author's transl)].
Bataini JP; Bernier J; de Narbonne J; Brugère J; Jaulerry C; Brunin F
Bull Cancer; 1978; 65(4):482-5. PubMed ID: 371710
[No Abstract] [Full Text] [Related]
[Next] [New Search]
